Anoctamin 2 identified as an autoimmune target in multiple sclerosis - Wikidata - awgldk - TriplyDB

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

http://www.wikidata.org/entity/Q28273167

about

Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy.Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.AAgAtlas 1.0: a human autoantigen database Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.Clonal Evolution of Autoreactive Germinal Centers.Untargeted screening for novel autoantibodies with prognostic value in first-episode psychosis.Antigen arrays for profiling autoantibody repertoires.Molecular, biophysical, and pharmacological properties of calcium-activated chloride channels.Advances in the development of human protein microarrays.Contrasting effects of phosphatidylinositol 4,5-bisphosphate on cloned TMEM16A and TMEM16B channels.Multiplexed Nucleic Acid Programmable Protein Arrays.A Systems Medicine Approach Reveals Disordered Immune System and Lipid Metabolism in Multiple Sclerosis Patients.Towards encoded particles for highly multiplexed colorimetric point of care autoantibody detection.Multiplex glycan bead array for high throughput and high content analyses of glycan binding proteins.

P2860

Q36216261-3412F55E-1C38-4E9E-90A8-7ADF14E05A43 Q36348434-9B5E6CD7-30B3-411B-8A79-9FA085929C2F Q37533397-90D18BD0-D1F4-4460-9BCE-7F7BD67D33F0 Q37557045-34EE4A22-E635-4EBB-9442-16F1CE5A78D6 Q37645937-07645828-9682-41B8-B416-95DFE162AD94 Q38608274-BB60221F-30ED-473B-B1A6-AE0682046519 Q38662607-7819BC22-528E-42DA-9525-9E0EF535B3C3 Q38812946-D673350B-DFB5-4506-B5B8-665EE0738F31 Q39102527-62EE75EE-7010-4DC3-8DA5-B76BDCB0A88C Q39394355-44A59C80-3D43-475A-8625-8A810A8EF32D Q41535576-A61A2045-75A2-45B5-88DC-3ED1C081BEBC Q45072132-1840E168-C13F-4C39-AB6E-A030E2E7AC2A Q47342256-06D81F58-524D-45E3-853B-882D8E476C97 Q48335841-347867F8-7955-4AC1-9217-B96BA01F9937 Q49870857-2C8C2757-6D1C-403E-BB19-E45435EFF626

P2860

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

http://www.wikidata.org/entity/Q28273167

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@ast

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@en

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@nl

type

label

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@ast

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@en

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@nl

prefLabel

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@ast

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@en

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@nl

P1433

Q28273167-F1047D82-F4C1-4046-8878-0F9E07A945F5

P1476

Q28273167-BC79C42F-78FE-413D-BE3D-A9645B6EC48E

P2093

Q28273167-4279CDE2-730A-4B60-8DEB-D454A6C6B7F6

Q28273167-482B93C8-EBB2-45C1-8131-F9DE96A24B26

Q28273167-52DCFB89-F42D-42D1-9EA6-FEB335F641AF

Q28273167-53FE006B-E06F-43F0-AE91-3E6C61DEA38B

Q28273167-6EF3DFF7-3D6F-40B4-AC3E-E412894D8806

Q28273167-810497BA-2CCE-472C-A63F-EF307B53CC86

Q28273167-BF2F2220-FE03-4530-ADF5-658ADF0CC1FA

P2860

Q28273167-004BB171-515B-4781-8A54-E265C1A3E503

Q28273167-058D5F2F-4B99-4A27-8E86-C730344F4CD2

Q28273167-0DD33349-63B4-409F-A3BC-1F1A83B71B25

Q28273167-0DDABA80-A826-4D9A-AB05-91E6056E371C

Q28273167-0EE523B4-CDCE-43E6-BA08-749BC389E701

Q28273167-23916573-18BD-4480-B3CD-1C3017E84105

Q28273167-277FDB0B-08DE-45A1-AEB8-A2EBEAB609FC

Q28273167-2FAADA82-EB5D-4465-820F-5A927C84F084

Q28273167-365E5527-4012-4E8C-A1FC-59864D8C2A28

Q28273167-39101984-63BD-4185-9679-516857AED0D4

P304

Q28273167-E60533B2-7DF2-4EE6-9E38-0B363845C9B0

P31

Q28273167-885062C0-31CB-4F81-85EF-2E72EE648552

P356

Q28273167-054F99CC-B4F6-4A0A-9C3D-840732223817

P407

Q28273167-D315DFF8-1635-4B97-8B01-77BDEB571A12

P433

Q28273167-41B2ECE9-2C96-4DBD-991A-02F9AEB398BB

P478

Q28273167-E6338293-5272-4A89-A5AA-9A622AA88CDA

P50

Q28273167-33A0B7BB-0E07-49F8-B029-4732973F3440

Q28273167-3DEB1174-9876-42A4-B36D-DAEE12D510E8

Q28273167-40BEDABE-1CBF-4570-9471-35B4CFCACED8

Q28273167-872256CA-1E68-448D-9CE1-4E2E9256BA8E

Q28273167-8A0CD0C0-8CDE-4D58-9863-336838DB2A74

Q28273167-90AE9885-06A2-440F-871B-38EAE08C2166

Q28273167-A4BCE7B2-83F3-4C94-AEF5-6B3532184AFD

Q28273167-C667B7E7-5DA0-4187-9A3E-FA7BF3B9D588

Q28273167-C6877B0E-DB38-4142-8590-54114F80FD22

Q28273167-E76CD928-36A4-4B85-9AF1-CBF58E66459C

P577

Q28273167-A6E274F2-95BE-452B-A5B4-C838751B3211

P5875

Q28273167-6ACA3CB9-483C-4877-9DF6-A83696A56E9E

P698

Q28273167-4B3EE564-DCBF-47EC-95F0-3442243D5BEB

P921

Q28273167-8278519D-EFE5-4ECE-85E1-8E65422698B5

P932

Q28273167-E59A075C-3E71-446A-B699-DEEAA632EE67

P356

PNAS.1518553113

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

@en

P2093

Björn Forsström

http://www.w3.org/2001/XMLSchema#string

Izaura Lima Bomfim

http://www.w3.org/2001/XMLSchema#string

Jochen M Schwenk

http://www.w3.org/2001/XMLSchema#string

Johan Bredenberg

http://www.w3.org/2001/XMLSchema#string

Ronald Sjöberg

http://www.w3.org/2001/XMLSchema#string

Tim Waterboer

http://www.w3.org/2001/XMLSchema#string

Tomas Olsson

http://www.w3.org/2001/XMLSchema#string

P2860

Anoctamins are a family of Ca2+-activated Cl- channels

TMEM16B, a novel protein with calcium-dependent chloride channel activity, associates with a presynaptic protein complex in photoreceptor terminals

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

X-ray structure of a calcium-activated TMEM16 lipid scramblase

Potassium channel KIR4.1 as an immune target in multiple sclerosis

ANO2 is the cilial calcium-activated chloride channel that may mediate olfactory amplification.

TMEM16A confers receptor-activated calcium-dependent chloride conductance

Expression and function of epithelial anoctamins

Proteomics. Tissue-based map of the human proteome

P304

2188-2193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1518553113

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Lars Alfredsson

Nicholas Mitsios

André Ortlieb Guerreiro-Cacais

Nada Abdelmagid

P577

2016-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293808115

http://www.w3.org/2001/XMLSchema#string

P698

26862169

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

4776531

http://www.w3.org/2001/XMLSchema#string